Charles & Colvard partners with Ethara Capital to expand Lab-Grown Diamond

Charles & Colvard Ltd, a globally recognised fine jewellery company that specialises in moissanite and lab-grown diamonds, today announced plans to expand its lab-grown diamond (“LGD”) offerings to consumers as well as wholesale markets with the supply chain support from its strategic investor, Ethara Capital, whose affiliates pioneered Chemical Vapour Deposition LGD manufacturing, and own and operate over 3,000 diamond-growing machines today.

In June, Ethara Capital announced a Convertible Secured Note Purchase Agreement with Charles & Colvard, and, in September, it converted the first 10% of its Note to the Company’s common equity.

“As consumer awareness of lab-grown diamonds continues to accelerate, we see a significant opportunity to expand our LGD products to leverage on our online platforms and wholesale distribution channels to meet that growing demand,” said Don O’Connell, President and CEO of Charles & Colvard. “We are excited to welcome Ethara and its affiliates as strategic investors and supply chain partners. Our partnership with Ethara Group, one of the largest growers in the LGD industry, brings to us an expanded, vertically integrated, and global supply chain of CVD lab-grown diamonds, and, we believe, will unlock tremendous growth opportunities for us,” continued O’Connell.

This partnership and ensuing product expansion initiative will broaden the Company’s Caydia® lab-grown diamond fine jewellery offerings with new bridal and fashion designs on charlesandcolvard.com, and, for the first time, enable approved retailers to purchase lab-grown diamonds through the Company’s B2B platform, charlesandcolvarddirect.com.